Key facts
- It has raised $4.4M; the latest was Seed Round ($4.4M) in Apr 2025.
- Notable investors include Creative Destruction Lab, Phoenix Court, Ahren Innovation Capital, Antonio Pellicer, Blue Wire Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Ovo Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Ovo Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ovo Labs
Developer of a healthcare technology designed to increase the chances of successful conception by improving the quality of eggs before fertilisation. The company is developing therapeutics that protect eggs from defects that can accumulate as women age and extend the timeline when the chances of conception are high, enabling women to turn their IVF (In Vitro Fertilization) attempt successfully by reducing genetic errors.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Employees
- 5
- Website
- ovo-labs.com/
- Ownership
- Privately Held (backing)
Ovo Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ovo Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ovo Labs in its N-PORT filings yet. We sweep new filings monthly.